 |
|
Mass Antibiotic Administration for Eradication of Ocular Chlamydia trachomatis
David Mabey, DM, FRCP;
Anthony W. Solomon, MRCP, PhD
JAMA. 2008;299(7):819-821.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Trachoma, a chronic keratoconjunctivitis caused by the bacterium Chlamydia trachomatis, is the leading infectious cause of blindness in the world. Until the 20th century it was endemic in Europe and North America, and eye hospitals established in the 19th century were founded to treat trachoma. As living standards improved, trachoma disappeared from the developed world, but it remains endemic in poor rural communities in some 55 countries, most of them in Africa and Asia. The World Health Organization (WHO) estimates suggest that more than 100 million individuals have the disease, of whom 7.6 million have potentially blinding sequelae, and 1.3 million are blind.1-2
In its early stages, mainly seen in children, trachoma causes few symptoms, but clinical signs may be observed in the conjunctiva of the everted upper eyelid, which takes on a roughened appearance due to the presence of . . . [Full Text of this Article]
Author Affiliations: Clinical Research Unit, London School of Hygiene & Tropical Medicine, London, England.
RELATED ARTICLE
Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma
Muluken Melese, Wondu Alemayehu, Takele Lakew, Elizabeth Yi, Jenafir House, Jaya D. Chidambaram, Zhaoxia Zhou, Vicky Cevallos, Kathryn Ray, Kevin Cyrus Hong, Travis C. Porco, Isabella Phan, Ali Zaidi, Bruce D. Gaynor, John P. Whitcher, and Thomas M. Lietman
JAMA. 2008;299(7):778-784.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Eliminating Trachoma
JWatch Infect. Diseases 2008;2008:4-4.
FULL TEXT
|
